Cervical Myelopathy
Conditions
Brief summary
To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic progression and response to treatment in patients with DCM. In addition, this repository will be used to develop a risk assessment scale to accurately predict functional outcomes following operative management of DCM.
Interventions
OTHERStandard clinical care procedures and outcome measurements.
Standard of care surgical interventions, imaging impressions, laboratory results, and outcome measurements will be collected and analyzed.
Sponsors
Francis Farhadi
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosis of degenerative cervical myelopathy * Diagnosis of cervical degenerative disease without myelopathy
Exclusion criteria
* None outside or diagnostic requirements and age limits.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Data comparison between DCM and control groups | 2 years | This study is to determine biomarkers associated with DCM and analyze objective clinical measures to determine more predictable and potentially effective treatments for patients diagnosed with cervical myelopathy. |
Countries
United States
Contacts
CONTACTFrancis Farhadi, MD, PhD
CONTACTHarshit Arora, PhD
PRINCIPAL_INVESTIGATORFrancis Farhadi, MD, PhD
University of Kentucky
Outcome results
None listed